238 related articles for article (PubMed ID: 21556941)
21. Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA.
Kim HR; Kim IK; Bae KH; Lee SH; Lee Y; Park TG
Mol Pharm; 2008; 5(4):622-31. PubMed ID: 18461969
[TBL] [Abstract][Full Text] [Related]
22. 1,4-Butanediol diglycidyl ether (BDE)-crosslinked PEI-g-imidazole nanoparticles as nucleic acid-carriers in vitro and in vivo.
Goyal R; Bansal R; Tyagi S; Shukla Y; Kumar P; Gupta KC
Mol Biosyst; 2011 Jun; 7(6):2055-65. PubMed ID: 21505659
[TBL] [Abstract][Full Text] [Related]
23. Unique Surface Modification of Silica Nanoparticles with Polyethylenimine (PEI) for siRNA Delivery Using Cerium Cation Coordination Chemistry.
Kapilov-Buchman Y; Lellouche E; Michaeli S; Lellouche JP
Bioconjug Chem; 2015 May; 26(5):880-9. PubMed ID: 25830668
[TBL] [Abstract][Full Text] [Related]
24. Target-specific gene silencing of layer-by-layer assembled gold-cysteamine/siRNA/PEI/HA nanocomplex.
Lee MY; Park SJ; Park K; Kim KS; Lee H; Hahn SK
ACS Nano; 2011 Aug; 5(8):6138-47. PubMed ID: 21739990
[TBL] [Abstract][Full Text] [Related]
25. Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung.
Günther M; Lipka J; Malek A; Gutsch D; Kreyling W; Aigner A
Eur J Pharm Biopharm; 2011 Apr; 77(3):438-49. PubMed ID: 21093588
[TBL] [Abstract][Full Text] [Related]
26. The packaging of siRNA within the mesoporous structure of silica nanoparticles.
Li X; Xie QR; Zhang J; Xia W; Gu H
Biomaterials; 2011 Dec; 32(35):9546-56. PubMed ID: 21906804
[TBL] [Abstract][Full Text] [Related]
27. Phosphorylatable short peptide conjugated low molecular weight chitosan for efficient siRNA delivery and target gene silencing.
Kong F; Liu G; Sun B; Zhou S; Zuo A; Zhao R; Liang D
Int J Pharm; 2012 Jan; 422(1-2):445-53. PubMed ID: 22067703
[TBL] [Abstract][Full Text] [Related]
28. Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine.
Al-Deen FN; Ho J; Selomulya C; Ma C; Coppel R
Langmuir; 2011 Apr; 27(7):3703-12. PubMed ID: 21361304
[TBL] [Abstract][Full Text] [Related]
29. Fabrication of a nanocarrier system through self-assembly of plasma protein and its tumor targeting.
Gong G; Zhi F; Wang K; Tang X; Yuan A; Zhao L; Ding D; Hu Y
Nanotechnology; 2011 Jul; 22(29):295603. PubMed ID: 21673386
[TBL] [Abstract][Full Text] [Related]
30. Self-assembling polyethylenimine derivatives mediate efficient siRNA delivery in mammalian cells.
Creusat G; Zuber G
Chembiochem; 2008 Nov; 9(17):2787-9. PubMed ID: 18972467
[No Abstract] [Full Text] [Related]
31. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery.
Katas H; Cevher E; Alpar HO
Int J Pharm; 2009 Mar; 369(1-2):144-54. PubMed ID: 19010405
[TBL] [Abstract][Full Text] [Related]
32. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing.
Liu X; Howard KA; Dong M; Andersen MØ; Rahbek UL; Johnsen MG; Hansen OC; Besenbacher F; Kjems J
Biomaterials; 2007 Feb; 28(6):1280-8. PubMed ID: 17126901
[TBL] [Abstract][Full Text] [Related]
33. A mesoporous silica nanoparticle--PEI--fusogenic peptide system for siRNA delivery in cancer therapy.
Li X; Chen Y; Wang M; Ma Y; Xia W; Gu H
Biomaterials; 2013 Jan; 34(4):1391-401. PubMed ID: 23164421
[TBL] [Abstract][Full Text] [Related]
34. Combined MUC1-specific nanobody-tagged PEG-polyethylenimine polyplex targeting and transcriptional targeting of tBid transgene for directed killing of MUC1 over-expressing tumour cells.
Sadeqzadeh E; Rahbarizadeh F; Ahmadvand D; Rasaee MJ; Parhamifar L; Moghimi SM
J Control Release; 2011 Nov; 156(1):85-91. PubMed ID: 21704663
[TBL] [Abstract][Full Text] [Related]
35. Polyethylenimine-PEG coated albumin nanoparticles for BMP-2 delivery.
Zhang S; Kucharski C; Doschak MR; Sebald W; Uludağ H
Biomaterials; 2010 Feb; 31(5):952-63. PubMed ID: 19878992
[TBL] [Abstract][Full Text] [Related]
36. Influence of acyl chain length on transfection mediated by acylated PEI nanoparticles.
Nimesh S; Aggarwal A; Kumar P; Singh Y; Gupta KC; Chandra R
Int J Pharm; 2007 Jun; 337(1-2):265-74. PubMed ID: 17254724
[TBL] [Abstract][Full Text] [Related]
37. Novel reduction-responsive cross-linked polyethylenimine derivatives by click chemistry for nonviral gene delivery.
Liu J; Jiang X; Xu L; Wang X; Hennink WE; Zhuo R
Bioconjug Chem; 2010 Oct; 21(10):1827-35. PubMed ID: 20828191
[TBL] [Abstract][Full Text] [Related]
38. Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation.
Langer K; Anhorn MG; Steinhauser I; Dreis S; Celebi D; Schrickel N; Faust S; Vogel V
Int J Pharm; 2008 Jan; 347(1-2):109-17. PubMed ID: 17681686
[TBL] [Abstract][Full Text] [Related]
39. Novel PEI/Poly-γ-Gutamic Acid Nanoparticles for High Efficient siRNA and Plasmid DNA Co-Delivery.
Peng SF; Hsu HK; Lin CC; Cheng YM; Hsu KH
Molecules; 2017 Jan; 22(1):. PubMed ID: 28054985
[TBL] [Abstract][Full Text] [Related]
40. The impact of carboxyalkylation of branched polyethylenimine on effectiveness in small interfering RNA delivery.
Oskuee RK; Philipp A; Dehshahri A; Wagner E; Ramezani M
J Gene Med; 2010 Sep; 12(9):729-38. PubMed ID: 20683834
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
